TUSTIN, Calif., Feb. 4 /PRNewswire-FirstCall/ -- AMDL, Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations China, announced today its Chairman and CEO Mr. Douglas MacLellan has appeared on Fox Business News today, Wednesday, February 4, 2009 at 6:40 a.m. ET (3:40 a.m. PT).
Mr. MacLellan was invited as a guest expert on Fox Business News to discuss the Chinese business environment specifically for pharmaceutical and healthcare companies, the Company's outlook for 2009 and its focus on growth in the emerging Chinese market, and how AMDL is leading the industry as one of the first US-based companies to enforce and implement Westernized business practices -- including SOX-compliant operating procedures and GAAP-certified accounting practices -- across its US and China operations.
According to Mr. MacLellan, "I'm extremely honored with an opportunity to address these important topics with Fox Business News. They are subjects investors inquire about most often when we communicate the AMDL story and topics that impact Wall Street's overall view and investing appetite for China-based pharmaceutical companies."
AMDL has successfully managed its US- and China-based operations despite the current economic downturn, delivering impressive and consistent revenue growth for the past four years. Over this period, the Company has achieved in excess of 100% YOY gross revenue growth and expects to continue that forward momentum in FY 2009. (www.amdl.com) To view the interview online visit Fox Business News at (http://www.foxbusiness.com/video/index.html).
FOX Business Network (FBN) is a financial news channel delivering real-time information across all platforms that impact both Main Street and Wall Street. FBN is headquartered in New York, the business capital of the world. Launched in October 2007, the Network is available in more than 35 million homes in major markets across the United States. Owned by News Corp., the Network has bureaus in Chicago, Los Angeles, Silicon Valley, Washington, DC and London. (www.foxbusiness.com).
Headquartered in Tustin, CA with operations in Shenzhen, Jiangxi, and Jilin, China, AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc. (JPI), is a vertically integrated pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. The company employs over 490 people in the U.S. and China. (www.amdl.com)
Forward Looking Statements:
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company's operations, markets, services, products, and prices. With respect to AMDL, Inc., except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.
AMDL Contact: Kristine Szarkowitz Director-Investor Relations firstname.lastname@example.org (Tel :) 206. 310.5323
|SOURCE AMDL, Inc.|
Copyright©2009 PR Newswire.
All rights reserved